Cytotoxic lanostanoid triterpenes from Ganoderma lucidum

Area of Science:

• Natural Products Chemistry
• Pharmacology
• Mycology

Background:

• Ganoderma lucidum (Lingzhi mushroom) is a well-known medicinal mushroom with a rich history in traditional medicine.
• Triterpenoids, particularly lanostanoids, are a major class of bioactive compounds found in Ganoderma species.
• Research into novel compounds from G. lucidum continues to explore its therapeutic potential.

Purpose of the Study:

• To isolate and characterize new lanostanoid triterpenes from the fruit bodies of Ganoderma lucidum.
• To evaluate the cytotoxic activity of the isolated compounds against various human cancer cell lines.

Main Methods:

• Isolation of compounds using chromatographic techniques.
• Structure elucidation employing advanced spectroscopic methods, including 2D-NMR and Mass Spectrometry (MS).
• Cytotoxicity assays using p388, Hela, BEL-7402, and SGC-7901 cancer cell lines.

Main Results:

• Two novel lanostanoid triterpenes, 23S-hydroxy-3,7,11,15-tetraoxo-lanost-8,24E-diene-26-oic acid (1) and 12beta-acetoxy-3beta-hydroxy-7,11,15,23-tetraoxo-lanost-8,20E-diene-26-oic acid (16), were identified.
• A total of 19 compounds, including 17 known ones, were isolated and characterized.
• The isolated compounds exhibited cytotoxic activity against the tested cancer cell lines, with IC50 values ranging from 8 to 25 micromolar.

Conclusions:

• The study successfully identified novel lanostanoid triterpenes from Ganoderma lucidum.
• The isolated compounds possess significant cytotoxic properties, suggesting potential as anticancer agents.
• Further investigation into the mechanism of action and structure-activity relationships is warranted.